BOLT
Bolt Biotherapeutics·NASDAQ
--
--(--)
--
--(--)
3.60 / 10
Netural
Money flow analysis shows a good score of 7.21/10, with large-cap inflows positive while overall and other segments trend negative—suggesting selective institutional interest. Analyst coverage is sparse (only one active analyst), but the consensus is overwhelmingly bullish (Strong Buy 100%). Historical win rates are low, so conviction remains moderate.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-20
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of BOLT?
- BOLT holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.60/10 (Netural).
